Literature DB >> 1936594

No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients.

I Puhakainen1, V A Koivisto, H Yki-Järvinen.   

Abstract

Increased gluconeogenesis has been suggested to account for all of the increase in basal glucose production in patients with non-insulin-dependent diabetes mellitus (NIDDM). We studied the effect of inhibition of gluconeogenesis with ethanol on total hepatic glucose output (HGO) in patients with NIDDM. Fourteen patients with NIDDM (mean +/- SE age 61 +/- 2 yr, fasting plasma glucose 11.4 +/- 0.8 mM; body mass index 27 +/- 1 kg/m2) were studied twice after an overnight fast, once during ethanol administration (blood ethanol approximately 12 mM) and once during saline administration. Total HGO rate was measured with [3H]glucose. Inhibition of gluconeogenesis by ethanol was followed qualitatively with [U-14C]lactate (n = 8) and [U-14C]glycerol (n = 6) as tracers. Ethanol inhibited gluconeogenesis from lactate by 71 +/- 5% (0.5 +/- 0.2 vs. 1.8 +/- 0.1 mumol glucose.kg-1.min-1, 240-300 min, P less than 0.001; ethanol vs. saline, P less than 0.001) and from glycerol by 65 +/- 6% (0.8 +/- 0.2 vs. 2.3 +/- 0.6 mumol glucose.kg.min-1, P less than 0.001). Total HGO rate remained unchanged and averaged 12.8 +/- 1.8 and 11.8 +/- 2.1 mumol.kg-1.min-1 in the saline and ethanol studies, respectively (NS). We concluded that inhibition of gluconeogenesis by ethanol does not decrease total HGO in patients with NIDDM. Our results suggest the existence of a regulatory mechanism in the liver that maintains constant total HGO despite inhibition of gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936594     DOI: 10.2337/diab.40.10.1319

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

2.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Alcohol consumption and risk of coronary heart disease among individuals with type 2 diabetes.

Authors:  M Tanasescu; F B Hu
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

4.  Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

Authors:  C Fanelli; S Calderone; L Epifano; A De Vincenzo; F Modarelli; S Pampanelli; G Perriello; P De Feo; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.

Authors:  L Rossetti; A Giaccari; N Barzilai; K Howard; G Sebel; M Hu
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

6.  Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.

Authors:  A Kotronen; A Seppälä-Lindroos; R Bergholm; H Yki-Järvinen
Journal:  Diabetologia       Date:  2007-11-16       Impact factor: 10.122

7.  20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

Authors:  Guangrui Lai; Jingjing Wu; Xiaoliang Liu; Yanyan Zhao
Journal:  Mol Endocrinol       Date:  2012-08-23

8.  The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

Authors:  C Saloranta; L Groop; A Ekstrand; A Franssila-Kallunki; M R Taskinen
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

9.  Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus.

Authors:  Anne E Bantle; William Thomas; John P Bantle
Journal:  Metabolism       Date:  2008-02       Impact factor: 8.694

10.  Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects.

Authors:  N Paquot; P Schneiter; E Jéquier; R Gaillard; P J Lefèbvre; A Scheen; L Tappy
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.